The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE).
Pheby, Derek F H, Araja, Diana, Berkis, Uldis et al.·Healthcare (Basel, Switzerland)·2020
This study created a unified European system for measuring how much ME/CFS costs society in terms of healthcare, lost work, and other expenses. The researchers found that ME/CFS places a heavy financial burden on Europe, mostly because patients lose work productivity. However, they discovered that calculating these true costs is very difficult because different countries use different diagnostic criteria and many doctors don't diagnose ME/CFS, leaving many patients uncounted.